[Naloxone doesn't determine the response of growth hormone to clonidine in obese patients].
The effect of naloxone (opioid receptor blocker) on the impairment of growth hormone (GH) release after clonidine (alfa 2-adrenergic agonist) was investigated in 10 volunteer obese subjects. The patients (4 males and 6 females, 16-22 year old) with fat excess (15 +/- 2 kg) estimated by bioelectrical impedance analysis (BIA) were studied repeatedly. The patients, were perfused by a slow saline infusion. 30 min later they received a bolus dose of clonidine (150 micrograms p.o.), followed 30 min later by a bolus dose of naloxone (10 mg i.v.) or a corresponding volume of isotonic sodium cloride (I.S.) for control. No significant changes occurred in blood GH concentration after clonidine administration and naloxone did not induce GH response at clonidine. These results suggest that in obese subjects the impairment of GH release after clonidine is not mediated via receptors sensitivity to naloxone.
Satta
M A
MA
Cattedra di Endocrinologia Università G. D'Annunzio, Chieti.
Castelli
A
A
Maussier
M L
ML
Scoppola
A
A
Valenza
V
V
Saletnich
I
I
Monaco
F
F
Roche
J
J
D000293:Adolescent; D000328:Adult; D003000:Clonidine / Q000494:pharmacology*; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D008297:Male; D009270:Naloxone / Q000494:pharmacology*; D009765:Obesity / Q000378:metabolism*
D009270:Naloxone; D013006:Growth Hormone; D003000:Clonidine
La naloxone ne détermine pas de réponse de l'hormone de croissance à la clonidine chez les obèses.